Implication of decreased serum complement 3 in patients with diabetic nephropathy
Authors:
- 17 October 2017
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 55 (1) , 31-39
Abstract
The serum complement 3 (C3) level was reduced in many patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN). However, the clinical implications of such change are still less understood. This study was aimed to explore the association between C3 level and the baseline clinicopathological characteristics and the prognosis of T2DM patients with DN.Keywords
Funding Information
- National Natural Science Foundation of China (81370823, 81670662)
This publication has 29 references indexed in Scilit:
- Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013JAMA, 2017
- Diabetic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2017
- Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986–2015Clinical Journal of the American Society of Nephrology, 2017
- Diagnosis and Management of Type 2 Diabetic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2017
- The role of the complement system in diabetic nephropathyNature Reviews Nephrology, 2017
- Standards of Medical Care in Diabetes—2017 Abridged for Primary Care ProvidersClinical Diabetes, 2017
- Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012JAMA, 2015
- Global estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Research and Clinical Practice, 2014
- Complement‐mediated chronic inflammation is associated with diabetic microvascular complicationDiabetes/Metabolism Research and Reviews, 2012
- Pathologic Classification of Diabetic NephropathyJournal of the American Society of Nephrology, 2010